<--- Back to Details
First PageDocument Content
Rare diseases / Orphan drugs / Nursing research / Niemann-Pick disease /  type C / NPC1 / Vorinostat / Clinical trial / Miglustat / Niemann–Pick disease / Health / Medicine / Lipid storage disorders
Date: 2014-09-10 20:05:09
Rare diseases
Orphan drugs
Nursing research
Niemann-Pick disease
type C
NPC1
Vorinostat
Clinical trial
Miglustat
Niemann–Pick disease
Health
Medicine
Lipid storage disorders

DEPARTMENT OF HEALTH & HUMAN SERVICES National Institutes of Health We are pleased to inform the NPC community of an upcoming clinical trial at the NIH to study the safety and tolerability of vorinostat in adults with N

Add to Reading List

Source URL: www.parseghian.org

Download Document from Source Website

File Size: 135,92 KB

Share Document on Facebook

Similar Documents

Exercise – Exploring sequence variant annotation in human The NPC1 (Niemann-Pick disease, type C1) gene encodes a protein that is thought to be involved in the intracellular transport of cholesterol. One of the varian

DocID: 1u8ku - View Document

FOR EMBARGOED USE ONLY Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease • •

FOR EMBARGOED USE ONLY Vtesse, Inc. Initiates Phase 2b/3 Clinical Trial of VTS-270 for Treatment of Niemann-Pick Type C1 (NPC) Disease • •

DocID: 1lXBa - View Document

3rd Annual BALTIMORE ORIOLES DILLON PAPIER’S BIRTHDAY BENEFIT Proceeds will fund Type C research for THE NATIONAL NIEMANN-PICK DISEASE FOUNDATION  Enjoy a ball game with friends and family on

3rd Annual BALTIMORE ORIOLES DILLON PAPIER’S BIRTHDAY BENEFIT Proceeds will fund Type C research for THE NATIONAL NIEMANN-PICK DISEASE FOUNDATION Enjoy a ball game with friends and family on

DocID: 1kTMM - View Document

WORKSHOP SUMMARY Sponsored by: Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) Office of the Commissioner, Office of Orphan Products Development (OOPD), FDA National Institutes of Healt

WORKSHOP SUMMARY Sponsored by: Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) Office of the Commissioner, Office of Orphan Products Development (OOPD), FDA National Institutes of Healt

DocID: ZxYc - View Document

Product Datasheet  Anti-Acid sphingomyelinase antibody [mAbcam74281] ab74281 1 Abreviews

Product Datasheet Anti-Acid sphingomyelinase antibody [mAbcam74281] ab74281 1 Abreviews

DocID: QysL - View Document